Skip to main content
Log in

Obstructive sleep apnea causes oxidative damage to plasma lipids and proteins and decreases adiponectin levels

  • Original Article
  • Published:
Sleep and Breathing Aims and scope Submit manuscript

Abstract

Pupose

Obstructive sleep apnea (OSA) is associated with various metabolic disorders, and oxidative stress was suggested to play an important role. In the present study, we aimed to investigate serum adiponectin and oxidative stress markers, especially protein carbonyls, and to evaluate the correlation between these parameters and lipid, insulin and fasting glucose concentrations in OSA patients and controls.

Method

Blood was drawn from healthy male volunteers following full-night polysomnographic evaluation. Subjects were classified as controls (n = 24), mild OSA group (n = 9) and moderate-severe OSA group (n = 17) according to their apnea–hypopnea indices (AHIs). Serum lipids, fasting glucose, adiponectin, malondialdehyde (MDA), protein carbonyl concentrations, and paraoxonase activities were measured in all subjects.

Results

Results of this study indicated that serum adiponectin concentrations were significantly decreased and MDA and protein carbonyl concentrations were significantly elevated in OSA patients compared to the controls. Protein carbonyl and MDA concentrations were significantly and positively correlated with AHI, while a significant negative correlation was found between adiponectin concentrations and AHI. Adiponectin levels were negatively correlated with MDA levels.

Conclusion

Results of this study, which is the first human study investigating and describing serum protein carbonyl concentrations in OSA patients, reveal that OSA causes increments in oxidative damage and decreases adiponectin levels. The recurrent hypoxia-reoxygenation attacks in OSA patients may activate oxidative stress, elevating sympathetic activity and leading to low levels of adiponectin.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Carpagnano GE, Kharitonov SA, Resta O, Foschino-Barbaro MP, Gramiccioni E, Barnes PJ (2003) 8-Isoprostane, a marker of oxidative stress, is increased in exhaled breath condensate of patients with obstructive sleep apnea after night is reduced by continious positive air way pressure therapy. Chest 124:1386–1392

    Article  PubMed  CAS  Google Scholar 

  2. Christou K, Markoulis N, Moulas AN, Pastaka C, Gourgoulianis KI (2003) Reactive oxygen metabolites (ROMs) as an index of oxidative stress in obstructive sleep apnea patients. Sleep Breath 7:105–110

    Article  PubMed  Google Scholar 

  3. Saarelainen S, Lehtimaki T, Jaak-Kola O, Poussa T, Nikkila M, Solakivi T, Nieminen MM (1996) Autoantibodies against oxidised low-density lipoprotein in patients with obstructive sleep apneoea. Clin Chem Lab Med 37:517–520

    Article  Google Scholar 

  4. Jordan W, Berger C, Cohrs S, Rodenbeck A, Mayer G, Niedmann PD, vanAhsen N, Rüther E, Kornhuber J, Bleich S (2004) CPAP-therapy efficiently lowers serum homocysteine in obstructive sleep apnea syndrome. J Neural Transm 111:683–689

    Article  PubMed  CAS  Google Scholar 

  5. Lavie L (2003) Obstructive sleep apnoea syndrome—an oxidative stress disorder. Sleep Med Rev 7:35–51

    Article  PubMed  Google Scholar 

  6. Banno K, Kryger MH (2007) Sleep apnea: clinical investigations in humans. Sleep Med 8:400–426

    Article  PubMed  Google Scholar 

  7. Ip MS, Lam B, Ng MM, Lam WK, Tsang KW, Lam KS (2002) Obstructive sleep apnea is independently associated with insulin resistance. Am J Respir Crit Care Med 165:670–676

    PubMed  Google Scholar 

  8. Punjabi NM, Sorkin JD, Katzel LI, Goldberg AP, Schwartz AR, Smith PL (2002) Sleepdisordered breathing and insulin resistance in middle-aged and overweight men. Am J Respir Crit Care Med 165:677–682

    PubMed  Google Scholar 

  9. Meslier N, Gagnadoux F, Giraud P, Person C, Ouksel H, Urban T, Racineux J-L (2003) Impaired glucose-insulin metabolism in males with obstructive sleep apnoea syndrome. Eur Respir J 22:156–160

    Article  PubMed  CAS  Google Scholar 

  10. Newman AB, Nieto FJ, Guidry U, Lind BK, Redline S, Shahar E, Pickering TG, Quan SF (2001) Sleep Heart Health Study Research Group. Relation of sleepdisordered breathing to cardiovascular disease risk factors: the Sleep Heart Health Study. Am J Epidemiol 154:50–59

    Article  PubMed  CAS  Google Scholar 

  11. McArdle N, Hillman D, Beilin L, Watts G (2007) Metabolic risk factors for vascular disease in obstructive sleep apnea: a matched controlled study. Am J Respir Crit Care Med 175:190–195

    Article  PubMed  CAS  Google Scholar 

  12. Tan KC, Chowa W-S, Lama JC, Lama B, Wong W-K, Tamb S, Ipl MS (2006) HDL dysfunction in obstructive sleep apnea. Atherosclerosis 184:377–382

    Article  PubMed  CAS  Google Scholar 

  13. Sharma SK, Kumpawat S, Goel A, Banga A, Ramakrishnan L, Chaturvedi P (2007) Obesity and not obstructive sleep apnea is responsible for metabolic abnormalities in a cohort with sleep disordered breathing. Sleep Medicine 8:12–17

    Article  PubMed  CAS  Google Scholar 

  14. Ciftci TU, Kokturk O, Bukan N, Bilgihan A (2005) Leptin and ghrelin levels in patients with obstructive sleep apnea syndrome. Respiration 72:395–401

    Article  Google Scholar 

  15. Punjabi NM, Sorkin JD, Katzel LI, Goldberg AP, Schwartz AR, Smith PL (2002) Sleep-disordered breathing and insulin resistance in middle-aged and overweight men. Am J Respir Crit Care Med 165:677–682

    PubMed  Google Scholar 

  16. Punjabi NM, Shahar E, Redline S, Gottlieb DJ, Givelber R, Resnick HE (2004) Sleep Heart Health Study Investigators. Sleepdisordered breathing, glucose intolerance, and insulin resistance: the sleep heart health Study. Am J Epidemiol 160:521–530

    Article  PubMed  Google Scholar 

  17. Lihn AS, Pedersen SB, Richelsen B (2005) Adiponectin: action, regulation and association to insulin sensitivity. Obes Rev 6:13–21

    Article  PubMed  CAS  Google Scholar 

  18. Fantuzzi G (2005) Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol 115:911–919

    Article  PubMed  CAS  Google Scholar 

  19. Masserini B, Morpurgo PS, Donadio F, Baldessari C, Bossi R, Beck-Peccoz P, Orsi E (2006) Reduced levels of adiponectin in sleep apnea syndrome. J Endocrinol Invest 29:700–705

    PubMed  CAS  Google Scholar 

  20. Harsch IA, Schahin SP, Radespiel-Tröger M, Weintz O, Jahreiss H, Fuchs FS, Wiest GH, Hahn EG, Lohmann T, Konturek PC, Ficker JH (2004) Continious positive airway pressure tratment rapidly improves insulin sensitivity in patients with obstructive sleep apnea syndrome. Am J Respir Crit Care Med 169:156–162

    Article  PubMed  Google Scholar 

  21. Makino S, Handa H, Suzukawa K, Fujiwara M, Nakamura M, Muraoka S, Takasago I, Tanaka Y, Hashimato K, Sugimoto T (2006) Obstructive sleep apnoea syndrome, plasma adiponectin levels, and insulin resistance. Clin Endocrinol 64:12–19

    Article  CAS  Google Scholar 

  22. Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S (1993) The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 328:1230–1235

    Article  PubMed  CAS  Google Scholar 

  23. Banno K, Walld R, Kryger MH (2005) Increasing obesity trends in patients with sleep breathing disorders referred to a sleep disorders centre. J Clin Sleep Med 1:364–366

    PubMed  Google Scholar 

  24. Vgontzas AN, Papanicolaou DA, Bixler EO, Kales A, Tyson K, Chrousos GP (1997) Elevation of plasma cytokines in disorders of excessive daytime sleepiness: role of sleep disturbance and obesity. J Clin Endocrinol Metab 82:1313–1316

    Article  PubMed  CAS  Google Scholar 

  25. Soares AF, Guichardant M, Cozzone D, Bernoud-Hubac N, Bouzaïdi-Tiali N, Lagarde M, Géloën A (2005) Effects of oxidative stress on adiponectin secretion and lactate production in 3T3-L1 adipocytes. Free Radic Biol Med 38:882–889

    Article  PubMed  CAS  Google Scholar 

  26. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412–419

    Article  PubMed  CAS  Google Scholar 

  27. Young IS, Trimble ER (1991) Measurement of malondialdehyde in plasma by high performance liquid chromatography with fluorimetric detection. Ann Clin Biochem 28:504–508

    PubMed  Google Scholar 

  28. Reznick AZ, Packer L (1994) Oxidative damage to proteins: spectrophotometric method for carbonyl assay. Methods Enzymol 233:357–363

    Article  PubMed  CAS  Google Scholar 

  29. Eckerson HW, Wyte CM, La Du BN (1983) The human serum paraoxonase/arylesterase polymorphism. Am J Hum Genet 35:1126–1138

    PubMed  CAS  Google Scholar 

  30. Lavie L, Vishnevsky A, Lavie P (2004) Evidence for lipid peroxidation in obstructive sleep apnea. Sleep 27:123–128

    PubMed  Google Scholar 

  31. Barcelo A, Miralles C, Barbe F, Vila M, Pons S, Agusti AG (2000) Abnormal lipid peroxidation in patients with sleep apnoea. Eur Respir J 16:644–647

    Article  PubMed  CAS  Google Scholar 

  32. Itzhaki S, Dorchin H, Clark G, Lavie L, Lavie P, Pillar G (2007) The effects of 1-year treatment with a herbst mandibular advancement splint on obstructive sleep apnea, oxidative stress, and endothelial function. Chest 131:740–749

    Article  PubMed  Google Scholar 

  33. Lavie L (2005) Sleep-disordered breathing and cerebrovascular disease: a mechanistic approach. Neurol Clin 23:1059–1075

    Article  PubMed  Google Scholar 

  34. Suzuki YJ, Jain V, Park AM, Day RM (2006) Oxidative stress and oxidant signaling in obstructive sleep apnea and associated cardiovascular diseases. Free Radic Biol Med 40:1683–1692

    Article  PubMed  CAS  Google Scholar 

  35. Arnardottir ES, Mackiewicz M, Gislason T, Teff KL, Pack AI (2009) Molecular sigantures of obstructive sleep apnea in adults: a riview and perspective. Sleep 32:447–470

    PubMed  Google Scholar 

  36. Sonka K, Fialová L, Volná J, Jiroutek P, Vávrová J, Kemlink D, Pretl M, Kalousová M (2008) Advanced oxidation protein products in obstructive sleep apnea. Prague Med Rep 109:159–165

    PubMed  CAS  Google Scholar 

  37. Tanriverdi H, Evrengul H, Kuru O, Tanriverdi S, Seleci D, Enli Y, Kaftan HA, Kilic M (2006) Cigarette smoking induced oxidative stress may impair endothelial function and coronary blood flow in angiographically normal coronary arteries. Circ J 70(5):593–599

    Article  PubMed  CAS  Google Scholar 

  38. Lavie P (2004) Evidence for lipid peroxidation in obstructive sleep apnea. Sleep 27(1):123–8

    PubMed  Google Scholar 

  39. Trujillo ME, Scherer PE (2005) Adiponectin—journey from an adipocyte secretory protein to biomarker of the metabolic syndrome. J Intern Med 257:167–175

    Article  PubMed  CAS  Google Scholar 

  40. Buckley TM, Schatzberg AF (2005) On the interactions of the hypothalamic–pituitary–adrenal (HPA) axis and sleep: normal HPA axis activity and circadian rythm, exemplary sleep disorders. J Clin Endocrinol Metab 90:3106–3114

    Article  PubMed  CAS  Google Scholar 

  41. Bruun JM, Lihn AS, Verdich C, Pedersen SB, Toubro S, Astrup A, Richelsen B (2003) Regulation of adiponectin by adipose tissue-derived cytokines: in vivo and in vitro investigations in humans. Am J Physiol Endocrinol Metab 285:527–533

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Esma Surmen-Gur.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Vatansever, E., Surmen-Gur, E., Ursavas, A. et al. Obstructive sleep apnea causes oxidative damage to plasma lipids and proteins and decreases adiponectin levels. Sleep Breath 15, 275–282 (2011). https://doi.org/10.1007/s11325-010-0378-8

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11325-010-0378-8

Keywords

Navigation